[Alpha Networks] Announcement of Shareholders' Meeting Resolution to Lift Non-Compete Restrictions for New Directors and Representatives
Key facts
- [Alpha Networks] Announcement of Shareholders' Meeting Resolution to Lift Non-Compete Restrictions for New Directors and Representatives
- Alpha Networks held its annual shareholders' meeting on May 26, 115, approving the lifting of non-compete restrictions for new directors and their representatives. The approval covers executives from Qisda Corporation and independent directors, allowing them to hold concurrent positions in various sectors, including healthcare and investment businesses in mainland China.
- Source: PR Times
- Date: May 26, 2026
Direct answer
Alpha Networks held its annual shareholders' meeting on May 26, 115, approving the lifting of non-compete restrictions for new directors and their representatives. The approval covers executives from Qisda Corporation and independent directors, allowing them to hold concurrent positions in various sectors, including healthcare and investment businesses in mainland China.
- Citation
- [Alpha Networks] Announcement of Shareholders' Meeting Resolution to Lift Non-Compete Restrictions for New Directors and Representatives (May 26, 2026), PR Times
- Source
- PR Times
- Date
- May 26, 2026
Alpha Networks held its annual shareholders' meeting on May 26, 115, approving the lifting of non-compete restrictions for new directors and their representatives. The approval covers executives from Qisda Corporation and independent directors, allowing them to hold concurrent positions in various sectors, including healthcare and investment businesses in mainland China.
📋 Article Processing Timeline
- 📰 Published: May 26, 2026 at 09:00
- 🔍 Collected: May 27, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 20:25 (108h 25m after Collected)
2. Names and Titles of Directors Permitted to Engage in Competitive Activities:
(1) Corporate Director: Qisda Corporation
(2) Corporate Director Representative: Huang Wen-fang
(3) Corporate Director Representative: Chen Chi-hung
(4) Corporate Director Representative: Huang Han-chou
(5) Corporate Director Representative: Hung Chiu-chin
(6) Independent Director: Li Shu-hsing
(7) Independent Director: Hsieh Ming-te
(8) Independent Director: Chiang Cheng-jung
(9) Independent Director: Chen Chung-jui
3. Scope of Permitted Competitive Activities: Includes various roles in Qisda Corporation, DFI Inc., AUO Corporation, BenQ Hospitals, and other affiliated entities.
4. Duration of Permission: During the tenure as a director or representative of the Company.
5. Resolution Status: Passed as proposed in accordance with Article 209 of the Company Act.
6. Competitive Activities in Mainland China: Involves Qisda Corporation and its representatives (Chen Chi-hung, Huang Han-chou, Hung Chiu-chin) in medical, investment, and manufacturing sectors.
7. Names and Titles in Mainland China: Chairman or Corporate Representative at BenQ Biotech (Shanghai), Nanjing BenQ Hospital, Suzhou BenQ Hospital, etc.
8. Locations in Mainland China: Shanghai, Nanjing, and Suzhou.
9. Business Scope in Mainland China: Medical device manufacturing, management consulting, medical services, investment holding, and material R&D.
10. Impact on Financials/Operations: None.
11. Investment Amount/Shareholding: None.
12. Other: None.
FAQ
What is Article 209 of the Taiwan Company Act?
It requires directors to obtain approval from the shareholders' meeting before engaging in any business activities that compete with the company's scope of operations.
What are the key facts in this article?
Alpha Networks held its annual shareholders' meeting on May 26, 115, approving the lifting of non-compete restrictions for new directors and their representatives. The approval covers executives from Qisda Corporation and independent directors, allowing them to hold concurrent positions in various sectors, including healthcare and investment businesses in mainland China.
What is the direct answer?
Alpha Networks held its annual shareholders' meeting on May 26, 115, approving the lifting of non-compete restrictions for new directors and their representatives. The approval covers executives from Qisda Corporation and independent directors, allowing them to hold concurrent positions in various sectors, including healthcare and investment businesses in mainland China.